Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Milestone Pharmaceuticals Inc. (MIST) had Income from Continuous Operations of $-20.76M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-20.76M |
|
-- |
|
-- |
|
$20.52M |
|
$-20.52M |
|
$-0.24M |
|
$-20.76M |
|
$-20.76M |
|
$-20.76M |
|
|
Income from Continuous Operations |
$-20.76M |
$-20.76M |
|
$-20.76M |
|
$-20.52M |
|
$-20.52M |
|
66.28M |
|
66.28M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$60.48M |
|
$0.18M |
|
$1.41M |
|
$61.88M |
|
$12.96M |
|
$54.29M |
|
$55.05M |
|
$68.01M |
|
$-6.12M |
|
$-6.12M |
|
$-6.12M |
|
53.46M |
|
| Cash Flow Statement Financials | |
$-13.95M |
|
$33.58M |
|
$0.14M |
|
$25.31M |
|
$45.09M |
|
$19.77M |
|
$1.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.67 |
|
-- |
|
-- |
|
1.13 |
|
-8.87 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.96M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
339.07% |
|
339.07% |
|
-33.55% |
|
-43.10% |
|
$-0.11 |
|
$-0.21 |
|
$-0.21 |
|